Best of Hematology Conference 2026
Friday, January 9, 2026
Conference Venue: InterContinental Toronto
Venue Address: 225 Front St W, Toronto, ON M5V 2X3
Directions: Google Maps Link
All in-person attendees are eligible for a chance to win an Apple Watch!*
Event Landscape
Chaired by Dr. Martina Trinkaus and Dr. Matthew Seftel, the Best of Hematology Conference 2026 will deliver a high-impact overview of the most important developments in the management of hematological malignancies over the past year.This focused event will feature expert-led presentations by leading oncologists and offer a curated review of key data and clinical insights from major international meetings in 2025. Designed for hematology professionals, the conference provides an outstanding opportunity to engage with peers, gain valuable updates, and remain at the cutting edge of hematology research and clinical practice.
Learning Objectives
- Analyze the most impactful oncology trials of 2025 across multiple disease sites, with a focus on key findings and their relevance to clinical practice.
- Review current standard-of-care treatment protocols for major hematologic malignancies, emphasizing evidence-based best practices and therapeutic advancements.
- Explore contemporary controversies and evolving perspectives in the management of select hematologic cancers.
Event Co-Chairs
Dr. Martina Trinkaus
MD, FRCPC
Dr. Martina Trinkaus is an assistant professor and staff hematologist at St. Michael’s Hospital with the University of Toronto. She completed her undergraduate training in Life Sciences and Physical Health and Education at Queen’s University and completed both her medical school and residency training at the University of Toronto. Since graduating from the Hematology training program in Toronto in 2009, she has remained at St. Michael’s Hospital practicing malignant hematology and serving on much education-based committees. She currently is the program director for the Adult Hematology Training Program and coordinates the hematology curriculum at St. Michael’s. Her medical interests include medical education with research focused on mentorship and e-based learning.
Dr. Matthew Seftel
MD, MPH
Dr. Matthew Seftel is a Hematologist based at Canadian Blood Services in Vancouver, where he serves as Medical Director for CBS Stem Cells. He is a clinical professor at the University of British Columbia. His academic interests are inBlood and Marrow Transplant/cellular therapy and complex hematological malignancies.
Sponsorship
For sponsorship-related inquiries, please contact your Director of Strategic Partnerships or visit our website
PLATINUM SPONSORS
All sales are final, refunds will not be accepted.
Please note mdBriefCase Group Inc. O/A Oncology Education cannot provide visa support for event attendees, including letters of invitation. Event attendees are solely responsible for obtaining any necessary documentation required for travel and participation in the event. No refunds shall be provided to individuals who are unable to attend.
Please be advised that video and photo recording will take place during this event. By registering and attending, you consent to being photographed and filmed. These materials may be used for promotional purposes, including but not limited to social media, websites, and other communication channels. If you have any concerns or wish to discuss this further, please contact us at [email protected] before the event.
Register Now
*Terms and Conditions
By registering to attend the Best of Hematology Conference, you will be automatically entered to win an Apple Watch. To be eligible, you must be a healthcare professional (sponsors and industry professionals excluded), and in attendance at Best of Hematology Conference in Toronto, ON. One (1) winner will be drawn at random at 3:45 PM ET on Friday, January 9, 2026. The winner must be in attendance to claim the prize and will be given 5 minutes to claim their prize at the event before another winner is chosen. The prize shall be accepted as awarded and is not transferable. The Apple Watch is valued at approximately $550 CAD and has no cash value and cannot be exchanged for cash. OncologyEducation reserves the right to substitute the Apple Watch with another prize or portion thereof of equal or greater value. Winners must be a natural person and cannot be a business, organization, or a non-living entity. By entering the Contest, entrants fully and unconditionally agree to be bound by these Rules and the decisions of OncologyEducation, which will be final and binding in all matters relating to the giveaway.
